|Phone||+44 1223 389001|
|Description||Single cell analysis technology|
|Venture Round, 2/13 |
London Business Angels
Sphere Fluidics is a new company targeting a combined market of Â£27 billion in the Drug Discovery and Development, Biofuels and Chemical Sciences industries.
Sphere is commercialising new lab-on-a-chip and picodroplet technology from Cambridge University that can perform thousands of simultaneous reactions on single cells and molecules contained within aqueous droplets, fractions of a millimetre in size.